Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases - Speth, F; Haas, J P; Hinze, C H (Pediatric rheumatology online journal, 2016)